Annual Shareholders Equity
$225.69 M
-$20.34 M-8.27%
December 31, 2023
Summary
- As of February 8, 2025, PMVP annual stockholders equity is $225.69 million, with the most recent change of -$20.34 million (-8.27%) on December 31, 2023.
- During the last 3 years, PMVP annual shareholders equity has fallen by -$133.43 million (-37.16%).
- PMVP annual shareholders equity is now -37.16% below its all-time high of $359.12 million, reached on December 31, 2020.
Performance
PMVP Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$197.91 M
-$16.41 M-7.66%
September 30, 2024
Summary
- As of February 8, 2025, PMVP quarterly stockholders equity is $197.91 million, with the most recent change of -$16.41 million (-7.66%) on September 30, 2024.
- Over the past year, PMVP quarterly shareholders equity has dropped by -$39.70 million (-16.71%).
- PMVP quarterly shareholders equity is now -46.36% below its all-time high of $368.97 million, reached on September 30, 2020.
Performance
PMVP Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
PMVP Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.3% | -16.7% |
| 3 y3 years | -37.2% | -16.7% |
| 5 y5 years | +589.1% | -16.7% |
PMVP Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -26.9% | at low | -35.9% | at low |
| 5 y | 5-year | -37.2% | +420.2% | -46.4% | +380.8% |
| alltime | all time | -37.2% | +420.2% | -46.4% | +380.8% |
PMV Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $197.91 M(-7.7%) |
| Jun 2024 | - | $214.31 M(+0.8%) |
| Mar 2024 | - | $212.68 M(-5.8%) |
| Dec 2023 | $225.69 M(-8.3%) | $225.69 M(-5.0%) |
| Sep 2023 | - | $237.61 M(+9.1%) |
| Jun 2023 | - | $217.81 M(-5.4%) |
| Mar 2023 | - | $230.17 M(-6.4%) |
| Dec 2022 | $246.03 M | $246.03 M(-5.8%) |
| Sep 2022 | - | $261.19 M(-5.7%) |
| Jun 2022 | - | $276.97 M(-5.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $291.84 M(-5.4%) |
| Dec 2021 | $308.56 M(-14.1%) | $308.56 M(-5.0%) |
| Sep 2021 | - | $324.95 M(-3.8%) |
| Jun 2021 | - | $337.85 M(-3.0%) |
| Mar 2021 | - | $348.30 M(-3.0%) |
| Dec 2020 | $359.12 M(-609.6%) | $359.12 M(-2.7%) |
| Sep 2020 | - | $368.97 M(+139.8%) |
| Jun 2020 | - | $153.90 M(-318.4%) |
| Dec 2019 | -$70.47 M(+52.7%) | -$70.47 M |
| Dec 2018 | -$46.14 M | - |
FAQ
- What is PMV Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals annual shareholders equity year-on-year change?
- What is PMV Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals quarterly shareholders equity year-on-year change?
What is PMV Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of PMVP is $225.69 M
What is the all time high annual shareholders equity for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high annual stockholders equity is $359.12 M
What is PMV Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, PMVP annual stockholders equity has changed by -$20.34 M (-8.27%)
What is PMV Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of PMVP is $197.91 M
What is the all time high quarterly shareholders equity for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high quarterly stockholders equity is $368.97 M
What is PMV Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, PMVP quarterly stockholders equity has changed by -$39.70 M (-16.71%)